These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18343567)

  • 1. Novel modes of oestrogen receptor agonism and antagonism by hydroxylated and chlorinated biphenyls, revealed by conformation-specific peptide recognition patterns.
    Sumbayev VV; Jensen JK; Hansen JA; Andreasen PA
    Mol Cell Endocrinol; 2008 Jun; 287(1-2):30-9. PubMed ID: 18343567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
    Shiau AK; Barstad D; Radek JT; Meyers MJ; Nettles KW; Katzenellenbogen BS; Katzenellenbogen JA; Agard DA; Greene GL
    Nat Struct Biol; 2002 May; 9(5):359-64. PubMed ID: 11953755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel pesticide-induced conformational state of the oestrogen receptor ligand-binding domain, detected by conformation-specific peptide binding.
    Sumbayev VV; Bonefeld-Jørgensen EC; Wind T; Andreasen PA
    FEBS Lett; 2005 Jan; 579(2):541-8. PubMed ID: 15642373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of agonism and antagonism in the oestrogen receptor.
    Brzozowski AM; Pike AC; Dauter Z; Hubbard RE; Bonn T; Engström O; Ohman L; Greene GL; Gustafsson JA; Carlquist M
    Nature; 1997 Oct; 389(6652):753-8. PubMed ID: 9338790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural aspects of agonism and antagonism in the oestrogen receptor.
    Pike AC; Brzozowski AM; Walton J; Hubbard RE; Bonn T; Gustafsson JA; Carlquist M
    Biochem Soc Trans; 2000; 28(4):396-400. PubMed ID: 10961927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist.
    Pike AC; Brzozowski AM; Hubbard RE; Bonn T; Thorsell AG; Engström O; Ljunggren J; Gustafsson JA; Carlquist M
    EMBO J; 1999 Sep; 18(17):4608-18. PubMed ID: 10469641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.
    Rodriguez AL; Tamrazi A; Collins ML; Katzenellenbogen JA
    J Med Chem; 2004 Jan; 47(3):600-11. PubMed ID: 14736241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gamma.
    Nam K; Marshall P; Wolf RM; Cornell W
    Biopolymers; 2003 Jan; 68(1):130-8. PubMed ID: 12579585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
    Celik L; Lund JD; Schiøtt B
    Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.
    Nilsson S; Koehler KF
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):15-25. PubMed ID: 15667591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways.
    Xia Y; Xing JZ; Krukoff TL
    Neuroscience; 2009 Aug; 162(2):292-306. PubMed ID: 19410635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A thermodynamic study of ligand binding to the first three domains of the human insulin receptor: relationship between the receptor alpha-chain C-terminal peptide and the site 1 insulin mimetic peptides.
    Menting JG; Ward CW; Margetts MB; Lawrence MC
    Biochemistry; 2009 Jun; 48(23):5492-500. PubMed ID: 19459609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogenic effects of selected hydroxy polychlorinated biphenyl congeners in primary culture of Atlantic Salmon (Salmo salar) hepatocytes.
    Braathen M; Mortensen AS; Sandvik M; Skåre JU; Arukwe A
    Arch Environ Contam Toxicol; 2009 Jan; 56(1):111-22. PubMed ID: 18414928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism.
    Nakabayashi M; Yamada S; Yoshimoto N; Tanaka T; Igarashi M; Ikura T; Ito N; Makishima M; Tokiwa H; DeLuca HF; Shimizu M
    J Med Chem; 2008 Sep; 51(17):5320-9. PubMed ID: 18710208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free energies of binding of polychlorinated biphenyls to the estrogen receptor from a single simulation.
    Oostenbrink C; van Gunsteren WF
    Proteins; 2004 Feb; 54(2):237-46. PubMed ID: 14696186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learnt from structural studies of the oestrogen receptor.
    Pike AC
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):1-14. PubMed ID: 16522516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro profiling of the endocrine disrupting potency of organochlorine pesticides.
    Li J; Li N; Ma M; Giesy JP; Wang Z
    Toxicol Lett; 2008 Dec; 183(1-3):65-71. PubMed ID: 18992306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding modes of PCBs to a degrading enzyme: a receptor-mapping study.
    Hornák V; Baláz S; Májeková M
    Gen Physiol Biophys; 1998 Jun; 17(2):105-16. PubMed ID: 9785099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent state.
    Mathiasen L; Dupont DM; Christensen A; Blouse GE; Jensen JK; Gils A; Declerck PJ; Wind T; Andreasen PA
    Mol Pharmacol; 2008 Sep; 74(3):641-53. PubMed ID: 18559377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reactivity pattern for discrimination of ER agonism and antagonism based on 3-D molecular attributes.
    Schmieder P; Koleva Y; Mekenyan O
    SAR QSAR Environ Res; 2002 Mar; 13(2):353-64. PubMed ID: 12071661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.